ESTRO 2025 - Abstract Book

S1217

Clinical – Lower GI

ESTRO 2025

Conclusion: In terms of long-term results, we observed that SIB-CRT can sustainably control local disease to improve LRFS and consequently generate OS and DFS benefits with no increase in late toxicities.

Keywords: Concomitant boost radiotherapy, long-term survival